Jay C. Butler

Jay C. Butler

Auto-generated profile, based on publicly available information

Jay C. Butler

Ctr Dis Control & Prevent, Atlanta, GA 30333 USA

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 January 2021 in JAMA Network Open
Verified
Journal Article
Closed access
PDF file
MJMichael A. Johansson
Michael A. Johansson
TQTalia M. Quandelacy
Talia M. Quandelacy
SKSarah Kada
Sarah Kada
PPPragati Venkata Prasad
Pragati Venkata Prasad
MSMolly Steele
Molly Steele
JBJay C. Butler
Jay C. Butler
As severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the novel coronavirus that causes coronavirus disease 2019 (COVID-19), began to spread globally, it became apparent that the virus, unlike the closely related SARS-CoV in the 2003 outbreak, could not be contained by symptom-based screening alone. Asymptomatic and clinically mild infections were uncommon during the 2003 SARS-CoV outbreak, and there were no reported instances of transmission from persons before the onset of symptoms.1 SARS-CoV-2 spread faster than SARS-CoV, and accumulating evidence showed that SARS-CoV-2, unlike SARS-CoV, is transmitted from persons without symptoms. However, measures to reduce transmission from individuals who do not have COVID-19 symptoms have become controversial and politicized and have likely had negative effects on the economy and many societal activities. Optimal control of COVID-19 depends on directing resources and health messaging to mitigation efforts that are most likely to prevent transmission. The relative importance of mitigation measures that prevent transmission from persons without symptoms has been disputed. Determining the proportion of SARS-CoV-2 transmission that occurs from persons without symptoms is foundational to prioritizing control practices and policies.

9 March 2000 in New England Journal of Medicine
Verified
Journal Article
Closed access
PDF file
JNJ. Pekka Nuorti
J. Pekka Nuorti
JBJay C. Butler
Jay C. Butler
MFMonica M. Farley
Monica M. Farley
LHLee H. Harrison
Lee H. Harrison
AMAllison McGeer
Allison McGeer
TTthe Active Bacterial Core Surveillance Team
the Active Bacterial Core Surveillance Team
Approximately half of otherwise healthy adults with invasive pneumococcal disease are cigarette smokers. We conducted a population-based case–control study to assess the importance of cigarette smoking and other factors as risk factors for pneumococcal infections.

1 January 1999 in Drugs & Aging
Verified
Journal Article
Closed access
PDF file
JBJay C. Butler
Jay C. Butler
ASAnne Schuchat
Anne Schuchat


1 April 1999 in Clinical Infectious Diseases
Verified
Journal Article
Open access
PDF file
JBJay C. Butler
Jay C. Butler
MCMartin S. Cetron
Martin S. Cetron
Streptococcus pneumoniae is a leading cause of illness and death among the elderly. The recent emergence of drug-resistant strains has complicated se

1 June 1998
Verified
Journal Article
Closed access
RBR F Breiman
R F Breiman
JBJ C Butler
J C Butler